Company CALTH. Inc

Equities

A402420

KR7402420004

Medical Equipment, Supplies & Distribution

Business Summary

Managers

Share class

Company contact information

Sector

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
12,890 ^KRW	+8.32%		+7.42%	0.00%

2022	CALTH. Inc announced that it has received KRW 1.9999872 billion in funding from Daewoong pharmaceutical Co.,Ltd, Kiwoom Securities Co., Ltd.	CI
2022	CALTH. Inc announced that it expects to receive KRW 1.9999872 billion in funding from Daewoong pharmaceutical Co.,Ltd, Kiwoom Securities Co., Ltd.	CI

Calth Inc is a Korea-based company principally engaged in the medical devices business. The Company is engaged in the manufacture and sale of in vitro diagnostics devices based on the immunochromatographic method such as rapid diagnostics tests and immunity analyzers. In addition, the Company is engaged in the research and development (R&D) of core technology, namely ion concentration polarization technology and others.

Managers	Title	Age	Since
Dong-Ho Lee CEO	Chief Executive Officer	55	-

	Vote	Quantity	Free-Float	Total Float
Stock A	0	185,184	0	17.08 %
Stock B	0	942,760	0
Stock C	0	316,474	0
Stock D	0	67,340	0
Stock E	0	336,700	0
Stock F	1	2,226,540	380,276 ( 17.08 %)
Stock G	0	62,500	0

CALTH, Inc.

#321, 54 Changeop-ro Sujeong-gu

13449, Seongnam-si

http://www.thecalth.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
CALTH. INC	0.00%	21.03M
BIOMÉRIEUX	-4.62%	12.18B
DIASORIN S.P.A.	+8.48%	5.96B
LANTHEUS HOLDINGS, INC.	+28.39%	5.45B
AUTOBIO DIAGNOSTICS CO., LTD.	-6.28%	4.34B
10X GENOMICS, INC.	-52.84%	3.18B
ANDON HEALTH CO., LTD.	+12.93%	2.75B
MYRIAD GENETICS, INC.	+28.84%	2.3B
VITROLIFE AB	-3.80%	2.28B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.64%	1.92B

Diagnostic & Testing Substances